Every AI express, investors ask on the investor interaction platform: did Tong Zhenming, the shareholder of the subsidiary, reduce his holdings yesterday? Before the time of announcement, on March 3, did you violate the rules in advance? In addition, is there a cash sale period for the shareholders who receive the large offer?
Jinghua Pharmaceutical Group Co.Ltd(002349) (002349. SZ) said on the investor interaction platform on February 18 that senxuan pharmaceutical, a subsidiary of the company, is a listed company on the Beijing stock exchange, and its shareholder reduction will be disclosed in accordance with the information disclosure rules.
